The synthesis of the potent and highly selective silicon-containing antimuscarinic agent o-methoxysila-hexocyclium methyl sulfate and its corresponding tertiary amine (isolated as the dihydrochloride) is described. The quarternary compound is an omethoxy derivative of sila-hexocyclium methyl sulfate, which represents one of the tools currently used in experimental pharmacology for the subclassification of muscarinic receptors. The omethoxy derivative, the pharmacological profile of which differs substantially from tbat of the nonmethoxy compound, is also recommended as a tool for the investigation of muscarinic receptor heterogeneity.
INTRODUCTION
Recently, we reported on the synthesis of the selective antimuscarinic agent sila-hexocyclium methyl sulfate (lb, Scheme 1).' This silanol, a silicon analogue of the spasmolytic and anti-ulcer agent hexocyclium methyl sulfate (la, Scheme 1), has become an important tool in experimental pharmacology for tTo whom correspondence should be addressed.
the classification of subtypes of muscarinic receptors. 2 • 3 lt shows approximately the samehigh affinity to muscarinic M 1 receptors in neuronal tissues and to M2ß receptors in smooth muscle organs and exocrine glands, whereas its antimuscarinic potency at cardiac M2a receptors is lower by more than one order of magnitude.
The corresponding o-methoxy derivative, omethoxy-sila-hexocyclium methyl sulfate (4), was also found to be a potent and highly selective antimuscarinic agent. The pharmacological profile, however, differs substantially from that of sila-hexocyclium methyl sulfate (lb). 4 A 22-fold difference in the affinity was found for 4 on neuronal M 1 receptors compared with the affinity to M2ß receptors in smooth muscle. Additionally, the affinity found for this agent on cardiac M2a receptors was lower than on M2ß receptors by a factor of 3 .5. Thus, the difference in affinity for omethoxy-sila-hexocyclium methyl sulfate (4) for MI over M2a receptors is 78-fold. To the best of our knowledge, silanol4 is the first quatemary amrnonium compound with high M 1 receptor selectivity.
Here we report on the synthesis of o-methoxy-silahexocyclium methyl sulfate (4) . In addition, the synthesis of its corresponding tertiary amine (isolated as the dihydrochloride 5) is described, the antimuscarinic properties of which are currently under investigation. This paper represents a further report on our systematic studies on sila-substituted drugs (for recent reviews on this subject, see Refs 5 and 6). 
Cyclohexylmethoxy(2·mathoxyphenyl)· [( 1-methylplperazln·4·yl)methyl]sllane (3)
A solution of n-butyllithium (60 mmol) in n-hexane (37.5 cm 3 ) at 0°C. After stirring for 1 h at room temperature and heating at reflux for 3 h, the reaction mixture was cooled to room . After stirring for 12 h at 20°C, the solvent was removed in vacuo and diethyl ether (150 cm 3 ) was added to the residue. The solid material formed was separated by filtration, washed with diethyl ether (80 cm 3 ) and dried in vacuo at 50°C. The solid was dissolved in water (120 cm 3 ) and the resulting solutionwas stirred for 1 hat 50°C. After removing the water in vacuo, the solid residue was crystallized from acetone/diethyl ether (2: 1, v/v) to give 2.7 g (yield 64%) of colourless crystals, m.p. 
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Cyclohexylmethoxy(2-methoxyphenyl)· [(1-methylplperazln-4-yl)methyl]sllanol dlhydrochlorlde (5)
Water (1 cm 3 ) was added to a solution of 3 (1.00 g, 2. 76 mmol) in diethyl ether (70 cm 3 ) , and the resulting reaction mixturewas stirred for 1 hat 20°C. The organic layer was quickly separated, dried over anhydrous Na 2 S0 4 and cooled to 0°C. A 0.5 mol dm-3 solution of hydrogen chloride in diethyl ether ( 14 cm 3 ) was added and the reaction mixture was stir- 
RESULTS AND DISCUSSION
The synthesis of o-methoxy-sila-hexocyclium methyi sulfate ( 4) is based on the approach developed for the preparation of the parent compound sila-hexocyclium methyl sulfate (lb) (see Ref. 1). Starting from readily available cyclohexyldimethoxy[ ( 1-methylpiperazin-4-yl)methyl]silane1 (2), 4 was prepared by a threestep synthesis with an overall yield of 44%. In the first step, the o-methoxypheny I group was introduced by reaction of 2 with o-methoxyphenyllithium in diethyl ether to give the corresponding arylsilane 3 (yield 68% ). Reaction of 3 with one equivalent of dimethyl sulfatein acetone at 20°C resulted in a selective quaternization of the nitrogen atom of the nitrogen-methyl (N-CH 3 ) group. Because of crystallization problems, the respective ammoniumderivative (characterized by 1 H NMR, 13 C NMR and FAB MS; data not given) could not be isolated as an analytically pure compound. Thus, after separation from the solvent and washing with diethyl ether, the quaternary product was hydrolyzed directly, without further purification, to give the silanol 4, which was obtained (after recrystallization from acetone/diethyl ether) in the form of analytically pure crystals (yield 64%, based on 3).
Hydrolysis of the methoxysilane 3 yielded the corresponding silanol which was not isolated and purified but converted directly into the dihydrochloride 5. After recrystallization from acetonitrile, 5 was obtained as an analytically pure compound (yield 77%, based on 3).
In the solid state, the silanals 4 and 5 are stable compounds which can be stored in closed flasks at room temperature without decomposition. In contrast, by analogy with other structurally related silanols, 4 and 5 can undergo a condensation reaction in solution to give the corresponding disiloxanes. However, the o-Methoxy-sila-hexocyclium methyl sulfate stability in diluted aqueous solution at room temperature was found to be sufficient to carry out the phannacological experiments without special stabilityrelated precautions.
